The DOI matches its Crossref record.
Predictors of Hemolytic Uremic Syndrome in Children During a Large Outbreak of Escherichia coli O157:H7 Infections
Abstract
Objective. To evaluate risk factors for progression of Escherichia coli O157:H7 infection to the hemolytic uremic syndrome (HUS). Study Design. We conducted a retrospective cohort study among 278 Washington State children <16 years old who developed symptomatic culture-confirmed E coli O157:H7 infection during a large 1993 outbreak. The purpose of the study was to determine the relative risk (RR) of developing HUS according to demographic characteristics, symptoms, laboratory test results, and medication use in the first 3 days of illness. Results. Thirty-seven (14%) children developed HUS. In univariate analysis, no associations were observed between HUS risk and any demographic characteristic, the presence of bloody diarrhea or of fever, or medication use. In multivariate analysis, HUS risk was associated with, in the first 3 days of illness, use of antimotility agents (odds ratio [OR] = 2.9; 95% confidence interval [CI] 1.2–7.5) and, among children <5.5 years old, vomiting (OR = 4.2; 95% CI 1.4–12.7). Among the 128 children tested, those whose white blood cell (WBC) count was ≥13 000/μL in the first 3 days of illness had a 7-fold increased risk of developing HUS (RR 7.2; 95% CI 2.8–18.5). Thirteen (38%) of the 34 patients with a WBC count ≥13 000/μL developed HUS, but only 5 (5%) of the 94 children whose initial WBC count was <13 000/μL progressed to HUS. Among children who did not develop HUS, use of antimotility agents in the first 3 days of illness was associated with longer duration of bloody diarrhea. Conclusions. Prospective studies are needed to further evaluate measures to prevent the progression of E coliO157:H7 infection to HUS and to assess further clinical and laboratory risk factors. These data argue against the use of antimotility agents in acute childhood diarrhea. Our finding that no intervention decreased HUS risk underscores the importance of preventing E coliO157:H7 infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Pathogenesis and Diagnosis of Shiga Toxin-Producing Escherichia coli Infections
Paton, J. C., & Paton, A. W. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.3.450 · Cited by 1,449
Wong, C. S., Jelacic, S., Habeeb, R. L., Watkins, S. L., & Tarr, P. I. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006293422601 · Cited by 1,094
Self-citationPractice Guidelines for the Management of Infectious Diarrhea
Guerrant, R. L., Van Gilder, T., Steiner, T. S., Thielman, N. M., Slutsker, L., Tauxe, R. V., Hennessy, T., Griffin, P. M., DuPont, H., Bradley Sack, R., et al. (2001) · Clinical Infectious Diseases · doi:10.1086/318514 · Cited by 1,074
Self-citationEnterohaemorrhagic Escherichia coli in human medicine
Karch, H., Tarr, P. I., & Bielaszewska, M. (2005) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2005.06.009 · Cited by 672
Self-citationShane, A. L., Mody, R. K., Crump, J. A., Tarr, P. I., Steiner, T. S., Kotloff, K., Langley, J. M., Wanke, C., Warren, C. A., Cheng, A. C., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix669 · Cited by 627
Self-citation
Metadata
- Authors
- Bell, B. P., Griffin, P. M., Lozano, P., Christie, D. L., Kobayashi, J. M., & Tarr, P. I.
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 1997-07-01
- Volume
- 100
- Issue
- 1
- Pages
- e12-e12
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W2168575705
- Cited by
- 237
- References
- 0
- FWCI
- 5.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Predictors of Hemolytic Uremic Syndrome in Children During a Large Outbreak of Escherichia coli O157:H7 Infections. https://app.cochat.ai/papers/10.1542/peds.100.1.e12
- The paper
- Bell, B. P., Griffin, P. M., Lozano, P., Christie, D. L., Kobayashi, J. M., & Tarr, P. I. (1997). Predictors of Hemolytic Uremic Syndrome in Children During a Large Outbreak of Escherichia coli O157:H7 Infections. Pediatrics. https://doi.org/10.1542/peds.100.1.e12
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.